Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Twin Peaks Medical Imaging (TPMI) is a healthcare technology company that specializes in artificial intelligence and machine learning for medical imaging analysis. The company developed a proprietary software platform designed to automate the measurement of body composition, such as muscle mass and adipose tissue, from routine CT scans. This technology provides clinicians with objective, quantitative data to assess conditions like sarcopenia and obesity, which are critical for patient risk stratification and surgical planning. In May 2021, TPMI was acquired by Riverain Technologies, a provider of AI-driven thoracic imaging solutions. The integration of TPMI's technology allows Riverain to offer more comprehensive clinical insights within its existing diagnostic workflow.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Twin Peaks Medical Imaging.